What are the most common mistakes with Teduglutide (Gattex / Revestive)?
The most common Teduglutide (Gattex / Revestive) mistakes are skipping the colonoscopy schedule (polyp risk is real); confusing GLP-2 with GLP-1 (different receptor, different indication); using it outside short-bowel indication. Most issues people run into come down to protocol and expectations, not the compound itself. Going in informed matters here because human evidence for Teduglutide (Gattex / Revestive) is limited.
Common Teduglutide (Gattex / Revestive) mistakes
- Skipping the colonoscopy schedule (polyp risk is real)
- Confusing GLP-2 with GLP-1 (different receptor, different indication)
- Using it outside short-bowel indication
Bloodwork worth tracking
- Colonoscopy at baseline + intervals
- ALT/AST
- Magnesium / electrolytes
References
- Teduglutide for the Treatment of Short Bowel Syndrome — Schwartz LK et al., NEJM, 2012
- Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure — Jeppesen PB, Pertkiewicz M, Messing B, et al. — Gastroenterology, 2012 (STEPS trial)
- GATTEX (teduglutide) for injection — FDA Prescribing Information — FDA / DailyMed (Takeda)
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Teduglutide (Gattex / Revestive)
Full Teduglutide (Gattex / Revestive) breakdownTeduglutide (Gattex / Revestive) what it's used forTeduglutide (Gattex / Revestive) side effectsTeduglutide (Gattex / Revestive) how to take itTeduglutide (Gattex / Revestive) who should avoid itTeduglutide (Gattex / Revestive) half-lifeTeduglutide (Gattex / Revestive) how long to workTeduglutide (Gattex / Revestive) legal statusTeduglutide (Gattex / Revestive) how it worksAsk the AI Coach
Last updated 2026-06-15.